EXACT Sciences Corporation

$53.39
(as of Jul 3, 12:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for EXACT Sciences Corporation

Stock Price
$53.39
Ticker Symbol
EXAS
Exchange
NASDAQ

Industry Information for EXACT Sciences Corporation

Sector
Healthcare
Industry
Diagnostics & Research

Company Description for EXACT Sciences Corporation

Country
USA
Full Time Employees
6,900

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Fundamentals for EXACT Sciences Corporation

Market Capitalization
$10,065,723,392
EBITDA
$38,092,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
2,500
Earnings per Share
$-5.53
Earnings per Share Estimate Next Year
Profit Margin
-36.06%
Shares Outstanding
188,638,000
Percent Owned by Insiders
0.92%
Percent Owned by Institutions
98.49%
52-Week High
52-Week Low

Technical Indicators for EXACT Sciences Corporation

50-Day Moving Average
200-Day Moving Average
RSI
49.61
2.09

Analyst Ratings for EXACT Sciences Corporation

Strong Buy
17
Buy
6
Hold
3
Sell
0
Strong Sell
0

News About EXACT Sciences Corporation

Jul 3, 2025, 9:00 AM EST
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. See more.
Jul 2, 2025, 8:11 AM EST
Chicago-based Tempus AI, Inc. See more.
Jun 30, 2025, 7:35 AM EST
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. See more.
Jun 29, 2025, 11:33 PM EST
Let’s dig into the relative performance of Natera (NASDAQ:NTRA) and its peers as we unravel the now-completed Q1 immuno-oncology earnings season. See more.